Sept 2025 Investor Update Letter
Post# of 31
(Total Views: 267)
Posted On: 09/19/2025 9:44:22 PM
Sept 2025 Investor Update Letter
Rosh Pina, Israel--(Newsfile Corp. - September 16, 2025) - IR-MED Inc. (OTCQB: IRME) ("IR-MED" or the "Company".), a developer of non-invasive artificial intelligence (AI)-powered spectrographic technology to address critical healthcare challenges, today published an investor update.
Dear Valued Investors,
As we enter September 2025, in addition to Q2 financial reports and to the 8K recently published, I find it appropriate to update you on the developments within our Company. As you will see from the information below, the Company has achieved meaningful milestones that could bring it closer to the start of commercial operations. In order to move from potential to realization, we need your continued support. Please note that based on the Company’s current expected level of operating expenditures, the Company’s cash resources as of June 30, 2025 , the Company’s ability to undertake the operational and strategic actions described in this update is contingent upon securing additional funding. The Company’s management is making active efforts through various financing avenues to obtain the required funding.
Read the rest of this article here .
Rosh Pina, Israel--(Newsfile Corp. - September 16, 2025) - IR-MED Inc. (OTCQB: IRME) ("IR-MED" or the "Company".), a developer of non-invasive artificial intelligence (AI)-powered spectrographic technology to address critical healthcare challenges, today published an investor update.
Dear Valued Investors,
As we enter September 2025, in addition to Q2 financial reports and to the 8K recently published, I find it appropriate to update you on the developments within our Company. As you will see from the information below, the Company has achieved meaningful milestones that could bring it closer to the start of commercial operations. In order to move from potential to realization, we need your continued support. Please note that based on the Company’s current expected level of operating expenditures, the Company’s cash resources as of June 30, 2025 , the Company’s ability to undertake the operational and strategic actions described in this update is contingent upon securing additional funding. The Company’s management is making active efforts through various financing avenues to obtain the required funding.
Read the rest of this article here .
(0)
(0)